Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illinois CancerCare is a leading independent oncology and hematology practice based in Peoria, Illinois, serving the central and western regions of the state. Founded in 1977, the practice operates over 14 clinic locations and is recognized as one of the largest community-based cancer care providers in the United States. The organization offers a comprehensive suite of services, including chemotherapy, radiation oncology, diagnostic imaging, and a specialized retail pharmacy. A core component of its mission is clinical research; the practice maintains a robust portfolio of over 100 active clinical trials through partnerships with the National Cancer Institute (NCI) and the Sarah Cannon Research Institute (SCRI). In September 2024, Illinois CancerCare was acquired by US Oncology, a network owned by McKesson, further expanding its access to advanced resources and therapeutic innovations. The practice remains dedicated to providing state-of-the-art treatments and compassionate care to patients in their local communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Illinois CancerCare.